These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8172234)

  • 1. High frequencies of human genetic diseases: founder effect with genetic drift or selection?
    Zlotogora J
    Am J Med Genet; 1994 Jan; 49(1):10-3. PubMed ID: 8172234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mutations responsible for frequent genetic diseases in isolated populations.
    Zlotogora J
    Eur J Hum Genet; 2007 Mar; 15(3):272-8. PubMed ID: 17213840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of autosomal recessive diseases among the Palestinian Arabs.
    Zlotogora J
    Am J Med Genet; 2002 May; 109(3):176-82. PubMed ID: 11977175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models for haplotype evolution in a nonstationary population.
    Fan R; Lange K
    Theor Popul Biol; 1998 Jun; 53(3):184-98. PubMed ID: 9679319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unexpectedly high frequency of heterozygosity for alpha-thalassemia in Ashkenazi Jews.
    Rund D; Filon D; Jackson N; Asher N; Oron-Karni V; Sacha T; Czekalska S; Oppenheim A
    Blood Cells Mol Dis; 2004; 33(1):1-3. PubMed ID: 15223003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.
    Peleg L; Frisch A; Goldman B; Karpaty M; Narinsky R; Bronstein S; Frydman M
    Eur J Hum Genet; 1998; 6(2):185-6. PubMed ID: 9781065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa.
    Richard P; Gaudon K; Haddad H; Ammar AB; Genin E; Bauché S; Paturneau-Jouas M; Müller JS; Lochmüller H; Grid D; Hamri A; Nouioua S; Tazir M; Mayer M; Desnuelle C; Barois A; Chabrol B; Pouget J; Koenig J; Gouider-Khouja N; Hentati F; Eymard B; Hantaï D
    Neurology; 2008 Dec; 71(24):1967-72. PubMed ID: 19064877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founder effect and genetic disease in Sottunga, Finland.
    O'Brien E; Jorde LB; Rönnlöf B; Fellman JO; Eriksson AW
    Am J Phys Anthropol; 1988 Nov; 77(3):335-46. PubMed ID: 3067585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary disorders among Iranian Jews.
    Zlotogora J
    Am J Med Genet; 1995 Jul; 58(1):32-7. PubMed ID: 7573153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population diversity and distinct haplotype frequencies associated with ACHE and BCHE genes of Israeli Jews from trans-Caucasian Georgia and from Europe.
    Ehrlich G; Ginzberg D; Loewenstein Y; Glick D; Kerem B; Ben-Ari S; Zakut H; Soreq H
    Genomics; 1994 Jul; 22(2):288-95. PubMed ID: 7806214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Finnish disease heritage].
    Kestilä M; Ikonen E; Lehesjoki AE
    Duodecim; 2010; 126(19):2311-20. PubMed ID: 21086689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania.
    Puffenberger EG
    Am J Med Genet C Semin Med Genet; 2003 Aug; 121C(1):18-31. PubMed ID: 12888983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population.
    Behar DM; Hammer MF; Garrigan D; Villems R; Bonne-Tamir B; Richards M; Gurwitz D; Rosengarten D; Kaplan M; Della Pergola S; Quintana-Murci L; Skorecki K
    Eur J Hum Genet; 2004 May; 12(5):355-64. PubMed ID: 14722586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One founder/one gene hypothesis in a new expanding population: Saguenay (Quebec, Canada).
    Heyer E
    Hum Biol; 1999 Feb; 71(1):99-109. PubMed ID: 9972101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human globin genes: what can we learn from their polymorphism?].
    Charmot-Bensimon D
    Bull Soc Pathol Exot; 1999; 92(4):242-8. PubMed ID: 10572659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic population structure of northern Sweden and its implications for mapping genetic diseases.
    Einarsdottir E; Egerbladh I; Beckman L; Holmberg D; Escher SA
    Hereditas; 2007 Nov; 144(5):171-80. PubMed ID: 18031350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage to Gaucher mutations in the Ashkenazi population: effect of drift on decay of linkage disequilibrium and evidence for heterozygote selection.
    Boas FE
    Blood Cells Mol Dis; 2000 Aug; 26(4):348-59. PubMed ID: 11042036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.